Pharma Two B, an Israeli company which develops fixed-dose combination drugs, has announced that it has raised $8 million in its second financing round. The company says that it will use the funds to continue the development of its early-stage Parkinson’s disease treatment.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israel's Top Hospital Unveils Program To Promote HealthTech Startups
September 12, 2024
Battery Startup Announces Superfast Charging For Electric Vehicles
September 12, 2024
Automated Marketing Firm Unveils New Image Editing Suite
September 11, 2024
Israeli Renewable Energy Firm Launches First US Solar Power Project
September 11, 2024
Facebook comments